SOLVENTUM CORPORATION Amortization of Intangible Assets
SOLVENTUM CORPORATION (SOLV) reported Amortization of Intangible Assets of $90.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- SOLVENTUM CORPORATION amortization of intangible assets for the quarter ending 2026-06-30 was $90.00M, a 15.38% increase year-over-year.
- SOLVENTUM CORPORATION amortization of intangible assets for the quarter ending 2026-03-31 was $90.00M, a 11.11% increase year-over-year.
- SOLVENTUM CORPORATION amortization of intangible assets for the quarter ending 2025-12-31 was $77.00M, a 12.50% decline year-over-year.
- SOLVENTUM CORPORATION amortization of intangible assets for the quarter ending 2025-09-30 was $77.00M, a 12.50% decline year-over-year.
- SOLVENTUM CORPORATION amortization of intangible assets for fiscal 2025 was $312.00M, a 10.60% decline from fiscal 2024.
- SOLVENTUM CORPORATION amortization of intangible assets for fiscal 2024 was $349.00M, a 4.38% decline from fiscal 2023.
- SOLVENTUM CORPORATION amortization of intangible assets for fiscal 2023 was $365.00M, a 2.14% decline from fiscal 2022.
- SOLVENTUM CORPORATION amortization of intangible assets for fiscal 2022 was $373.00M.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $90.00M 10-Q · filed 2026-08-05 | $181.00M 10-Q · filed 2026-08-05 | $257.00M derived: sum of 3 quarters · filed 2026-08-05 | $334.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $90.00M 10-Q · filed 2026-05-05 | $167.00M derived: sum of 2 quarters · filed 2026-05-05 | $244.00M derived: sum of 3 quarters · filed 2026-05-05 | $322.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $154.00M derived: sum of 2 quarters · filed 2026-02-27 | $232.00M derived: sum of 3 quarters · filed 2026-08-05 | $312.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $77.00M 10-Q · filed 2025-11-06 | $155.00M derived: sum of 2 quarters · filed 2026-08-05 | $235.00M 10-Q · filed 2025-11-06 | $324.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $78.00M 10-Q · filed 2026-08-05 | $159.00M 10-Q · filed 2026-08-05 | $247.00M derived: sum of 3 quarters · filed 2026-08-05 | $335.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $81.00M 10-Q · filed 2026-05-05 | $169.00M derived: sum of 2 quarters · filed 2026-05-05 | $257.00M derived: sum of 3 quarters · filed 2026-05-05 | $343.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $176.00M derived: sum of 2 quarters · filed 2026-02-27 | $262.00M derived: sum of 3 quarters · filed 2026-02-27 | $349.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $88.00M 10-Q · filed 2025-11-06 | $174.00M derived: sum of 2 quarters · filed 2025-11-06 | $261.00M 10-Q · filed 2025-11-06 | $350.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $86.00M 10-Q · filed 2025-08-08 | $173.00M 10-Q · filed 2025-08-08 | $262.00M derived: sum of 3 quarters · filed 2026-02-27 | $354.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $87.00M 10-Q · filed 2025-05-09 | $176.00M derived: sum of 2 quarters · filed 2026-02-27 | $268.00M derived: sum of 3 quarters · filed 2026-02-27 | $360.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $181.00M derived: sum of 2 quarters · filed 2026-02-27 | $273.00M derived: sum of 3 quarters · filed 2026-02-27 | $365.00M 10-K · filed 2026-02-27 |
| 2023-09-30 | $92.00M 10-Q · filed 2024-11-08 | $184.00M derived: sum of 2 quarters · filed 2024-11-08 | $276.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $92.00M 10-Q · filed 2024-08-09 | $184.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $92.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $373.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |